A team at Dundee University looked at chronic lymphocytic leukaemia (CLL), the most common form of leukaemia, and how it reacted to treatment with the drug Tenovin.
Tenovin was developed by scientists in St Andrews and Dundee several years ago and has been found to kill off CLL cells by interfering with the process of "self-digestion" that leukaemic cells use to protect themselves.




